2,478 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Acquired by XTX Topco Ltd

XTX Topco Ltd purchased a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,478 shares of the company's stock, valued at approximately $459,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. First Horizon Advisors Inc. grew its position in Inspire Medical Systems by 885.7% in the 4th quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock valued at $26,000 after buying an additional 124 shares in the last quarter. Huntington National Bank raised its holdings in Inspire Medical Systems by 228.3% during the fourth quarter. Huntington National Bank now owns 174 shares of the company's stock worth $32,000 after purchasing an additional 121 shares in the last quarter. Harbour Investments Inc. boosted its stake in Inspire Medical Systems by 101.0% during the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company's stock valued at $37,000 after purchasing an additional 99 shares in the last quarter. AlphaQuest LLC raised its stake in shares of Inspire Medical Systems by 7,275.0% in the 4th quarter. AlphaQuest LLC now owns 295 shares of the company's stock worth $55,000 after buying an additional 291 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in Inspire Medical Systems by 61.9% during the fourth quarter. Quadrant Capital Group LLC now owns 327 shares of the company's stock valued at $61,000 after purchasing an additional 125 shares during the last quarter. Institutional investors own 94.91% of the company's stock.

Insider Buying and Selling

In related news, CTO John Rondoni sold 583 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the completion of the transaction, the chief technology officer now directly owns 10,424 shares in the company, valued at approximately $1,777,187.76. This trade represents a 5.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Randy Ban sold 25,584 shares of Inspire Medical Systems stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the sale, the insider now directly owns 7,259 shares in the company, valued at approximately $1,332,026.50. This represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. 4.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on INSP. Piper Sandler reduced their price objective on Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating for the company in a research note on Monday, February 10th. Morgan Stanley decreased their price target on shares of Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a report on Tuesday, February 11th. Wells Fargo & Company decreased their target price on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a research note on Tuesday, February 11th. Stifel Nicolaus reduced their price objective on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a research report on Monday. Finally, Robert W. Baird lowered their price target on Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems presently has a consensus rating of "Moderate Buy" and an average target price of $218.90.

Inspire Medical Systems Stock Up 0.3 %

Inspire Medical Systems stock traded up $0.43 during trading hours on Friday, hitting $158.63. The stock had a trading volume of 76,184 shares, compared to its average volume of 581,559. Inspire Medical Systems, Inc. has a fifty-two week low of $123.00 and a fifty-two week high of $257.40. The company has a market cap of $4.72 billion, a PE ratio of 91.98, a price-to-earnings-growth ratio of 2.86 and a beta of 1.39. The company has a 50-day moving average of $163.29 and a two-hundred day moving average of $181.75.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. As a group, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.